STUB1 and breast carcinoma: Among them, 6 patients had TP53 variants, and their TP53 variants co-existed in the ctDNA and DNA from tumor biopsies (Supplementary Table S1 and Supplementary Figure S2), suggesting the TP53 variants origin from breast cancer, not CHIP mutations.